How Stock-Backed Financing Powers Corporate Action
Without Equity Dilution
Unlock the Value of Your Listed Shares Without
Selling Them
In today's highly competitive global capital markets, access
to timely and efficient financing has become a strategic advantage. Public
companies, major shareholders, founders, family offices, and institutional
investors often require substantial liquidity to support corporate expansion,
mergers and acquisitions, rights issues, debt refinancing, infrastructure
development, or other strategic investments.
However, conventional financing
options frequently present significant challenges. Selling a large block of
listed shares may generate immediate liquidity, but it can also trigger market
selling pressure, reduce ownership, dilute voting control, and eliminate future
upside potential. Traditional bank financing, meanwhile, often requires lengthy
approval procedures, fixed asset collateral, extensive documentation, and
restrictive lending conditions.
For sophisticated investors and corporate decision-makers, a
more efficient alternative exists.
Asset-Backed Financing,
commonly structured as Loan Against Listed Shares (LASS) or Securities-Based
Lending (SBL), enables qualified borrowers to unlock the value of their
publicly listed shares while continuing to retain ownership of those assets.
The Capital Challenge Facing Public Companies
Every growing company eventually reaches a point where rapid
access to capital becomes essential. Whether funding an acquisition,
subscribing to a Rights Issue, constructing a new manufacturing facility,
refinancing outstanding debt, or pursuing international expansion, timing is
often critical.
Traditional financing methods each
involve significant trade-offs:
- Selling listed shares permanently reduces ownership.
- New equity issuance dilutes existing shareholders.
- Conventional bank loans often require property or fixed
assets as collateral.
- Commercial lending may involve lengthy credit approvals
and restrictive financial covenants.
For founders and controlling
shareholders, selling shares may also send unintended negative signals to the
market, potentially affecting investor confidence and share price performance.
A financing solution that preserves
ownership while providing immediate liquidity has therefore become increasingly
valuable.
What Is Loan Against Listed Shares (LASS)?
Loan Against Listed Shares (LASS),
also known internationally as Securities-Based Lending (SBL), is an
institutional financing structure whereby eligible publicly listed shares are
pledged as collateral to secure a loan from an institutional lender.
Instead of selling valuable equity
holdings, borrowers temporarily leverage the market value of their listed
shares to obtain financing while maintaining their long-term investment position.
Unlike
conventional commercial lending, where the primary focus is on cash flow or
hard assets, LASS evaluates several important factors, including:
- Market value of the listed shares
- Trading liquidity
- Market capitalization
- Historical price volatility
- Exchange listing
- Portfolio concentration
- Borrower's financial profile
- Institutional credit policy
Because the collateral consists of marketable securities,
qualified transactions may benefit from a more streamlined financing process
than traditional lending structures.
The Mechanism of Non-Recourse Stock
Financing
Through PT Nurin Inti Global's
network of institutional lending partners, qualified borrowers may access
financing secured by eligible listed shares under carefully structured
institutional lending programs.
High Loan-to-Value (LTV)
Qualified portfolios may obtain
financing of up to 70% Loan-to-Value (LTV), subject to lender approval,
portfolio eligibility, market conditions, and the quality of the pledged
securities.
Competitive Institutional Interest Rates
Qualified
borrowers may benefit from competitive institutional financing rates
typically ranging from 2% to 4% per annum (APR).
The applicable interest rate depends
on several factors, including:
- Quality of the listed shares
- Trading liquidity
- Market capitalization
- Portfolio size
- Stock price volatility
- Borrower's profile
- Transaction structure
- Final institutional credit assessment
Higher-quality, more liquid listed
securities generally qualify for more favorable financing terms.
No Upfront Financing Fees
One of the significant advantages of
this institutional financing program is that qualified transactions
generally do not require upfront financing fees before loan approval and
closing.
Borrowers
are not expected to pay advance financing charges merely for submitting an
application or having their portfolio evaluated.
Where applicable, any legal
documentation, custody, or transaction-related costs will be clearly disclosed
by the institutional lender during the due diligence and documentation process.
This transparent approach helps borrowers evaluate financing
opportunities without unnecessary upfront financial commitments.
Non-Recourse Protection
For
eligible financing structures, the loan is secured exclusively by the pledged
listed shares.
No additional personal guarantees
may be required, allowing borrowers to separate personal assets from the
pledged investment portfolio, subject to the final transaction structure.
Preservation of Ownership
Unlike selling shares, borrowers continue to retain
beneficial ownership of their listed securities.
This means they continue to participate in future capital
appreciation while avoiding equity dilution and preserving long-term
shareholder value.
Tier-One
Institutional Custody
All pledged securities are maintained through segregated
custody arrangements with leading institutional custodians.
This
structure provides:
- Independent custody
- Transparent valuation
- Regulatory compliance
- Institutional-grade security
throughout the financing period.
Why More Companies Choose Stock-Backed Financing
Compared
with traditional lending, Loan Against Listed Shares offers several strategic
advantages.
|
Traditional
Bank Loan |
Loan
Against Listed Shares (LASS) |
|
Property or fixed assets required |
Listed shares serve as collateral |
|
Often lengthy approval process |
Streamlined institutional
assessment |
|
May require extensive collateral |
Based primarily on eligible listed
securities |
|
Potential equity dilution through
alternative funding |
No equity dilution |
|
Selling shares may reduce
ownership |
Ownership is preserved |
|
Limited financing flexibility |
Broad range of permitted corporate
purposes (subject to loan agreement) |
|
Conventional lending structure |
International institutional
financing solution |
Strategic Applications
Stock-backed financing provides
flexibility for numerous corporate purposes.
Typical applications include:
Rights Issues
Major shareholders can obtain
liquidity to subscribe for new shares without selling existing holdings,
thereby maintaining their ownership percentage.
Mergers & Acquisitions (M&A)
Rapid access to institutional
financing allows companies to pursue strategic acquisitions when opportunities
arise.
Corporate Debt Refinancing
Companies with expensive existing financing may refinance
using competitive institutional interest rates, typically ranging from 2% to
4% per annum for qualified transactions, subject to lender approval.
Working Capital
Obtain liquidity to support daily
operations without liquidating valuable long-term investments.
Project Development
Finance renewable energy projects, manufacturing facilities,
industrial expansion, infrastructure development, and other capital-intensive
investments.
Capital Expenditure (CAPEX)
Purchase equipment, machinery, production lines, or
industrial assets while preserving strategic equity ownership.
Why Choose PT Nurin Inti Global?
PT Nurin Inti Global acts as an independent financial
advisor, introducer, and transaction facilitator specializing in
institutional securities-backed financing.
We connect qualified borrowers with reputable international
institutional lenders while maintaining the highest standards of
professionalism and confidentiality.
Our institutional financing
solutions are designed to offer:
- Up to 70% Loan-to-Value
(LTV) for qualified portfolios.
- Competitive institutional interest rates, typically ranging from 2%–4% APR, depending on
the quality of the pledged listed shares.
- No upfront financing fees for qualified transactions.
- Funding that may be completed within 1–3 business
days after due diligence, legal documentation, and closing conditions
have been satisfied.
- Loan tenors generally ranging from 6 to 24 months.
- Tier-One institutional segregated custody.
- Strict confidentiality throughout the transaction
process.
- Cross-border institutional financing capabilities.
Our objective is to help clients unlock the value of their
listed share portfolios without sacrificing ownership or long-term investment
potential.
Conclusion
Your listed shares represent more than an investment—they
are valuable financial assets that can support future growth without being
sold.
Whether
your objective is funding a Rights Issue, refinancing existing debt, expanding
operations, executing an acquisition, or financing a major capital project,
Loan Against Listed Shares offers a sophisticated institutional solution
designed to preserve ownership while providing efficient access to liquidity.
Rather than selling your most
valuable assets, consider leveraging them strategically to accelerate growth
and strengthen your financial position.
FREQUENTLY ASKED QUESTIONS (FAQ) Click here
Contact
AHMAD FAKAR
Financial Introducer
PT Nurin Inti Global
📧 Email: nuringlobal@gmail.com
📱 WhatsApp: +62 813 686 43249
🌐 Website: https://www.im2win.com
Important Notice
PT
Nurin Inti Global acts solely as an independent financial advisor,
introducer, and facilitator. PT Nurin Inti Global is not a lender
and does not make credit or underwriting decisions.
All loan approvals, Loan-to-Value
(LTV), financing terms, interest rates, transaction structures, custody
arrangements, and eligibility are determined exclusively by the institutional
lending partner based on its independent credit assessment, the quality and
liquidity of the pledged listed shares, applicable regulations, and prevailing
market conditions.
References
to up to 70% LTV, indicative interest rates of 2%–4% per annum, no
upfront financing fees for qualified transactions, and funding that may
be completed within 1–3 business days are indicative only and remain
subject to lender approval, successful due diligence, legal documentation,
portfolio eligibility, and satisfaction of all closing conditions.
